,i  #aaf? ,,congress  #a/ ,session  ,h4 
,r4 #ejeg  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,novemb] #ab1         
#bjai,mr4 ,tonko 7= himself & ,mr4      
,mc,kinley7 introduc$ ! foll[+ bill2 :i*
 0 ref]r$ to ! ,committee on ,en]gy &   
,comm]ce1 & 9 addition to ! ,committee  
on ,ways & ,means1 = a p]iod to be      
subsequ5tly det]m9$ by ! ,speak]1 9 ea* 
case = consid]ation ( su* provisions z  
fall )9 ! jurisdiction ( ! committee    
conc]n$  ,a ,,bill  ,to cl>ify !        
treatm5t ( pass-?r\gh /atus "u ! ,m$ic>e
 outpati5t paym5t sy/em = c]ta9 drugs4  
#a4 ,%ort title ,?is ,act may be cit$ z 
! ,pass-,?r\gh ,te*nical ,corrections   
,act4  #b4 ,cl>ification ( pass-?r\gh   
/atus "u ,m$ic>e ,,opps = c]ta9 drugs   
,not)/&+ section #acja ( ! ,consolidat$ 
,appropriations ,act ( #bjah 7,public   
,law #aae-ada71 9 ! case ( a            
radioph>maceutical drug = :i* pass-?r\gh
 /atus 0 provid$ pursuant to section    
#ahcc7t77#f7 ( ! ,social ,security ,act 
7#db ,u4,s4,c4 #aciel7t77#f77 & ^: p]iod

 ( pass-?r\gh /atus initially expir$ on 
ei!r ,decemb] #ca1 #bjag1 or ,decemb]   
#ca1 #bjah1 if su* radioph>maceutical   
drug is indicat$ = positron emission    
tomography beta amyloid imag+ cov]$ "u a
 cov]age evid5ce developm5t det]m9ation 
"u section #ahfb7;a77#a77;,e7 ( !       
,social ,security ,act 7#db ,u4,s4,c4   
#aciey7a77#a77;,e771 !n su* pass-?r\gh  
/atus %all be ext5d$ until su* date t ! 
cov]age ) evid5ce developm5t review is  
det]m9$ by ! ,c5t]s = ,m$ic>e  ,m$icaid 
,s]vices to be complet$4